Teens and young adults are at increased risk for meningococcal disease. Meningococcal
disease is a very serious illness, and while there are vaccines available and guidelines for
vaccination against types A, C, W and Y are clear, type B is becoming increasingly widespread.
This trial will study a vaccine that targets all 5 types of invasive meningococcal disease.
To qualify for the trial you must:
● Be between 10 and 25 years old
● Not have any chronic, immune, neurological, or psychiatric illnesses
● Not have received certain types of meningococcal vaccines in the past*
● Other criteria may apply**
*Candidates may need to provide vaccination records.
**Eligibility for studies may require specific demographics such as age and/or symptoms.
Eligible candidates will be compensated for time and travel.
To learn more about this trial and to find out if you qualify, please call 402.934.0044 or complete the form on our contact page.